Skip to content

Study · Animal study (in vivo) · mouse · 2019

1 result

β1-adrenergic receptors mediate plasma acyl-ghrelin elevation and depressive-like behavior induced by chronic psychosocial stress.

Gupta D, Chuang JC, Mani BK, Shankar K, Rodriguez JA, Osborne-Lawrence S, Metzger NP, Zigman JM

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology8 Feb 2019Cited by 32 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In male mice under chronic social defeat stress, chronic delivery of the GHSR agonist GHRP‑2 during and after stress did not improve depressive-like behavior.

    In plain wordsIn mice under chronic social stress, GHRP‑2 given during and after the stress did not improve depressive-like behavior.

    Peptide
    GHRP-2
    Outcome
    No significant changeDepressive-like behavior after chronic GHRP-2 delivery in CSDS
    Study

    mousen: not reported in source

    10-day chronic social defeat stress (CSDS) in male mice
    Outcome group
    Anxiety and mood · Mental health and mood
    Studied dose
    Dose not stated · during and after CSDSAs given in this study (mouse).

    Source sentences

    Summary
    nor chronic delivery of GHRP-2 during and after CSDS improved stress-induced depressive-like behavior
    2 context sentences
    Summary · context
    the synthetic GHSR agonist GHRP-2 during and/or after CSDS.
    Summary · context
    Here, we used a pharmacological approach in combination with a 10-day chronic social defeat stress (CSDS) model in male mice to investigate whether the sympathoadrenal system is involved in the ghrelin response to stress.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.